Mengzhou Wang

机构：Sarepta Therapeutics (United States), Pharmaceutical Biotechnology (Czechia), Shaanxi University of Science and Technology · ORCID：0000-0001-6942-6286

发表论文 35 篇 · 总被引 1070 次 · h-index 17

代表论文

• Involvement of GPX4 in irisin's protection against ischemia reperfusion‐induced acute kidney injury (2020 · Journal of Cellular Physiology · 被引 137)
• Milk fat globule EGF factor 8 restores mitochondrial function via integrin‐medicated activation of the FAK‐STAT3 signaling pathway in acute pancreatitis (2021 · Clinical and Translational Medicine · 被引 49)
• Clinical Significance of Serum Albumin/Globulin Ratio in Patients With Pyogenic Liver Abscess (2021 · Frontiers in Surgery · 被引 40)
• New insight into polystyrene ion exchange resin for efficient cesium sequestration: The synergistic role of confined zirconium phosphate nanocrystalline (2023 · Chinese Chemical Letters · 被引 36)
• Identification of irisin as a therapeutic agent that inhibits oxidative stress and fibrosis in a murine model of chronic pancreatitis (2020 · Biomedicine & Pharmacotherapy · 被引 32)
• Blocking CIRP protects against acute pancreatitis by improving mitochondrial function and suppressing pyroptosis in acinar cells (2024 · Cell Death Discovery · 被引 30)